Ocugen, Inc. SEC filings OCGN
Ocugen, Inc. has 892 filings in SEC EDGAR's recent list, going back to Aug 7, 2006. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 4, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 5, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | May 28, 2024 | Dec 31, 2023 |
| 10-K/A | Amended annual report | Apr 29, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Apr 16, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 20, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 28, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 28, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 19, 2021 | Dec 31, 2020 |
| 10-K/A | Amended annual report | Apr 29, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 27, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 22, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 15, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Mar 16, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Mar 10, 2016 | Dec 31, 2015 |
| 10-K | Annual report | Mar 27, 2015 | Dec 31, 2014 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- OCGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Malvern, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1372299
- Former names
- HISTOGENICS CORP (until Sep 26, 2019)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.